FibroGen
FGEN
FGEN
100 hedge funds and large institutions have $62.8M invested in FibroGen in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 22 closing their positions.
Holders
100
Holders Change
-10
Holders Change %
-9.09%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
34
Reduced
31
Closed
22
Calls
$1.72M
Puts
$58K
Net Calls
+$1.66M
Net Calls Change
-$15K
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$8.65M |
| 2 |
2
D.E. Shaw & Co
New York
|
$1.66M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$2.12M |
| 4 |
4
Acadian Asset Management
Boston,
Massachusetts
|
$2.19M |
| 5 |
PI
5
Pennant Investors
Summit,
New Jersey
|
$681K |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$6.24M |
| 2 |
2
Millennium Management
New York
|
$538K |
| 3 |
3
BlackRock
New York
|
$6.39M |
| 4 |
4
Jane Street
New York
|
$333K |
| 5 |
5
Squarepoint
New York
|
$0 |
